Fluoroquinolone Resistance in Drug-Resistant Tuberculosis, Kharkiv, Ukraine, 2019-2023

被引：0

作者：

Konstantynovska, Olha ^{[1
,2
,3
]}

Synenko, Tetiana ^{[2
]}

Honcharenko, Alla ^{[2
]}

Volobuieva, Olha ^{[2
,3
]}

Liadova, Tetiana ^{[3
]}

Reimann, Maja ^{[4
,5
]}

Lange, Christoph ^{[4
,5
,6
,7
,8
]}

Chesov, Dumitru ^{[4
,5
,9
]}

机构：

[1] Imperial Coll London, London, England

[2] Kharkiv Reg Phthisiopulmonol Ctr, Kharkiv, Ukraine

[3] Kharkov Natl Univ, Kharkiv, Ukraine

[4] Leibniz Lung Ctr, Borstel, Germany

[5] German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Ri, Germany

[6] Univ Lubeck, Lubeck, Germany

[7] Baylor Coll Med, Houston, TX USA

[8] Texas Childrens Hosp, Global TB Program, Houston, TX USA

[9] Nicolae Testemitanu State Univ Med & Pharm, Kishinev, Moldova

来源：

EMERGING INFECTIOUS DISEASES | 2025年 / 31卷 / 03期

关键词：

OUTCOMES;

D O I：

10.3201/eid3103.241675

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Rifampin-resistant Mycobacterium tuberculosis was identified by the World Health Organization as a pathogen of public health critical importance. During 2014-2023, an increase in fluoroquinolone resistance in rifampin-resistant M. tuberculosis from Kharkiv, Ukraine, was observed. Efforts to mitigate factors contributing to resistance should be prioritized to prevent further escalation of that threat.

引用

页码：615 / 617

页数：3

共 50 条

[1] Conflict and drug-resistant tuberculosis in Ukraine
Acosta, Colleen D.
Kaluski, Dorit N.
Dara, Masoud
LANCET, 2014, 384 (9953): : 1500 - 1501
[2] A new treatment for drug-resistant tuberculosis in Ukraine
Holt, Ed
LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 23 - 23
[3] Multidrug-resistant tuberculosis in the Kharkiv Region, Ukraine
Butov, D.
Lange, C.
Heyckendorf, J.
Kalmykova, I
Butova, T.
Borovok, N.
Novokhatskaya, M.
Chesov, D.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2020, 24 (05) : 485 - 491
[4] Improved Fluoroquinolone-Resistant and Extensively Drug-Resistant Tuberculosis Treatment Outcomes
Lee, Eun Hye
Yong, Seung Hyun
Leem, Ah Young
Lee, Sang Hoon
Kim, Song Yee
Chung, Kyung Soo
Jung, Ji Ye
Park, Moo Suk
Kim, Young Sam
Chang, Joon
Kang, Young Ae
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (04):
[5] Australian recommendations for the management of drug-resistant tuberculosis, 2023
Stapledon, Richard
Natl TB Advisory Comm
COMMUNICABLE DISEASES INTELLIGENCE, 2023, 47
[6] Mutations leading to drug-resistant Mycobacterium tuberculosis infection in Ukraine
Antonenko, Kate O.
Kresyun, Valentin I.
Antonenko, Peter B.
CENTRAL EUROPEAN JOURNAL OF MEDICINE, 2010, 5 (01): : 30 - 35
[7] Isoniazid resistance and the future of drug-resistant tuberculosis
Cohen, T
Becerra, MC
Murray, MB
MICROBIAL DRUG RESISTANCE, 2004, 10 (04) : 280 - 285
[8] Resistance pattern in drug-resistant pulmonary tuberculosis
Nagaraja, C.
Shashibhushan, B. L.
Sagar, C.
Asif, M.
Manjunath, P. H.
JOURNAL OF POSTGRADUATE MEDICINE, 2011, 57 (03) : 181 - 183
[9] Risk assessment and transmission of fluoroquinolone resistance in drug-resistant pulmonary tuberculosis: a retrospective genomic epidemiology study
Nehru, Vijayalakshmi Jawaharlal
Jose Vandakunnel, Maria
Brammacharry, Usharani
Ramachandra, Venkateswari
Pradhabane, Gunavathy
Mani, Balasundaram Revathi
Dusthackeer, Azger V. N.
Muthaiah, Muthuraj
SCIENTIFIC REPORTS, 2024, 14 (01):
[10] Drug-resistant tuberculosis and HIV in Ukraine: a threatening convergence of two epidemics?
Dubrovina, I.
Miskinis, K.
Lyepshina, S.
Yann, Y.
Hoffmann, H.
Zaleskis, R.
Nunn, P.
Zignol, M.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2008, 12 (07) : 756 - 762

← 1 2 3 4 5 →